title: Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins.
abstract: BACKGROUND
  Better understanding of the mechanisms involved in docosahexaenoic acid (DHA) transfer to the neonate may contribute to improve dietary support for infants born prematurely to mothers with placental lipid transport disorders.
  
  
  OBJECTIVE
  We studied whether DHA supplements modify the messenger RNA (mRNA) expression of placental lipid transport proteins to allow a selective transfer of DHA to the fetus.
  
  
  METHODS
  Healthy pregnant women (n = 136) received, in a double-blind randomized trial, 500 mg DHA + 150 mg eicosapentaenoic acid, 400 microg 5-methyl-tetrahydrofolic acid, 500 mg DHA + 400 microg 5-methyl-tetrahydrofolic acid, or placebo during the second half of gestation. We analyzed the fatty acid composition of maternal and cord blood phospholipids and of placenta; we quantified placental mRNA expression of fatty acid-transport protein 1 (FATP-1), FATP-4, FATP-6, fatty acid translocase, fatty acid-binding protein (FABP) plasma membrane, heart-FABP, adipocyte-FABP, and brain-FABP.
  
  
  RESULTS
  The mRNA expression of the lipid carriers assayed did not differ significantly between the 4 groups. However, the mRNA expression of FATP-1 and FATP-4 in placenta was correlated with DHA in both maternal plasma and placental phospholipids, although only FATP-4 expression was significantly correlated with DHA in cord blood phospholipids. Additionally, the mRNA expression of several membrane lipid carriers was correlated with EPA and DHA in placental triacylglycerols and with EPA in placental free fatty acids.
  
  
  CONCLUSIONS
  Correlation of the mRNA expression of the membrane placental proteins FATP-1 and especially of FATP-4 with maternal and cord DHA leads us to conclude that these lipid carriers are involved in placental transfer of long-chain polyunsaturated fatty acids.
authors.affiliation: Division of Metabolic Diseases and Nutritional Medicine, Dr von Hauner Children Hospital, Ludwig Maximilians University of Munich, Munich, Germany.
authors.forename: Elvira
authors.initials: E
authors.lastname: Larqué
authors.forename: Susanne
authors.initials: S
authors.lastname: Krauss-Etschmann
authors.forename: Cristina
authors.initials: C
authors.lastname: Campoy
authors.forename: Dominik
authors.initials: D
authors.lastname: Hartl
authors.forename: Javier
authors.initials: J
authors.lastname: Linde
authors.forename: Mario
authors.initials: M
authors.lastname: Klingler
authors.forename: Hans
authors.initials: H
authors.lastname: Demmelmair
authors.forename: Africa
authors.initials: A
authors.lastname: Caño
authors.forename: Angel
authors.initials: A
authors.lastname: Gil
authors.forename: Brigitta
authors.initials: B
authors.lastname: Bondy
authors.forename: Berthold
authors.initials: B
authors.lastname: Koletzko
mesh_terms: D000328:Adult; D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D004311:Double-Blind Method; D050612:Fatty Acid Transport Proteins / Q000097:blood / Q000235:genetics / Q000378:metabolism*; D050556:Fatty Acid-Binding Proteins / Q000378:metabolism; D005260:Female; D006801:Humans; D010920:Placenta / Q000187:drug effects* / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D011247:Pregnancy / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D050612:Fatty Acid Transport Proteins; D050556:Fatty Acid-Binding Proteins; D012333:RNA, Messenger; D004281:Docosahexaenoic Acids